Clinical utility of microarrays: Current status, existing challenges and future outlook

Current Genomics

Volumn 9, Issue 7, 2008, Pages 466-474

  Li, Xinmin ^a   Quigg, Richard J ^b   Zhou, Jian ^a   Gu, Weikuan ^c   Nagesh Rao, P ^a   Reed, Elaine F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

23andMe; AmpliChip CYP450; AmpliChip p53; deCODE genetics; MammaPrint; Microarray; Navigenics; Tissue of tumor origin

Indexed keywords

AMITRIPTYLINE; ANTINEOPLASTIC AGENT; ATOMOXETINE; CARVEDILOL; CLOMIPRAMINE; CODEINE; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; DESIPRAMINE; DEXTROMETHORPHAN; DNA; FLECAINIDE; HALOPERIDOL; IMIPRAMINE; LANSOPRAZOLE; METOPROLOL; MEXILETINE; OMEPRAZOLE; ONDANSETRON; PANTOPRAZOLE; PAROXETINE; PROPAFENONE; PROTEIN P53; RISPERIDONE; RNA; TAMOXIFEN; TIMOLOL; TRAMADOL; UNINDEXED DRUG; VENLAFAXINE;

BREAST CANCER; CHROMOSOME ABERRATION; CLINICAL LABORATORY; DIAGNOSTIC TEST; DNA MICROARRAY; DRUG DETERMINATION; DRUG RESEARCH; GENE TECHNOLOGY; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HEALTH CARE DELIVERY; HUMAN; INTERNET; MEDICAL INSTRUMENTATION; MICROARRAY ANALYSIS; NONHUMAN; ONLINE SYSTEM; REVIEW;

EID: 60849126175     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920208786241199     Document Type: Review

References (29)

1. Gutman, S. I., Kessler, L. G. The US Food and Drug Administration perspective on cancer biomarker development. Nat. Rev. Cancer 2006, 6: 565-571.
2. Lababidi, S. Challenges in DNA Microarray Studies from the Regulatory Perspective. J. Biopharm. Stat. 2008, 18: 183-202.
3. Wang, Y., Klijn, J.G., Zhang, Y., Sieuwerts, A.M., Look, M.P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M.E., Yu, J., Jatkoe, T., Berns, E.M., Atkins, D., Foekens, J.A. Gene expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365: 671-679.
4. Campbell, G. Some issues in the statistical evaluation of genetic and genomic tests. J. Biopharm. Stat. 2004, 14: 539-552.
5. Tezak, Z., Ranamukhaarachchi, D., Russek-Cohen, E., Gutman, S. I. FDA perspectives on potential microarray-based clinical diagnostics. Hum. Genomics 2006, 2: 236-243.
6. Daly, A.K. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam. Clin. Pharmacol. 2003, 17: 27-41.
7. de Leon, J., Susce, M.T., Murray-Carmichael, E. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool. Mol. Diagn. Ther. 2006, 10: 135-151.
8. Heller, T., Kirchheiner, J., Armstrong, V.W., Luthe, H., Tzvetkov, M., Brockmöller, J., Oellerich, M. AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther. Drug Monit. 2006, 28: 673-677.
9. Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Thun, M. Trends in breast cancer by race and ethnicity. CA Cancer J. Clin. 2003, 53: 342-355.
10. Fisher, B., Jeong, J.H., Bryant, J., Anderson, S., Dignam, J., Fisher, E.R., Wolmark, N. National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Treatment of lymph-node-negative, oestrogenreceptor-positive breast cancer: longterm findings from National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Lancet 2004, 364: 858-868.
11. Dobbe, E., Gurney, K., Kiekow, S., Lafferty, J.S., Kolesar, J.M. Gene-expression assays: new tools to individualize treatment of early-stage breast cancer. Am. J. Health Syst. Pharm. 2008, 65: 23-28.
12. Glas, A.M., Floore, A., Delahaye, L.J., Witteveen, A.T., Pover, R.C., Bakx, N., Lahti-Domenici, J.S., Bruinsma, T.J., Warmoes, M.O., Bernards, R., Wessels, L.F., Van't Veer, L.J. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 2006, 7: 278.
13. Mook, S., Van't Veer, L.J., Rutgers, E.J., Piccart-Gebhart, M.J., Cardoso, F. Individualization of therapy using Mammaprint: from development to the MINDACT Trial. Cancer Genomics Proteomics 2007, 4: 147-155.
14. Buyse, M., Loi, S., van't Veer, L., Viale, G., Delorenzi, M., Glas, A.M., d'Assignies, M.S., Bergh, J., Lidereau, R., El Bogaerts, J., Therasse, P., Floore, A., Amakrane, M., Piette, F., Rutgers, E., Sotiriou, C., Cardoso, F., Piccart, M.J., Consortium, T. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J. Natl. Cancer Inst. 2006, 98: 1183-1192.
15. Morrisa, S.R., Carey, L.A. Gene expression profiling in breast cancer. Curr. Opin. Oncol. 2007, 19: 547-551.
16. Bloom, G., Yang, I.V., Boulware, D., Kwong, K.Y., Coppola, D., Eschrich, S., Quackenbush, J., Yeatman, T.J. Multi-Platform, Multi-Site, Microarray-Based Human Tumor Classification. Am. J. Pathol. 2004, 164: 9-16.
17. Nakhleh, R.E., Zarbo, R.J. Amended reports in surgical pathology and implications for diagnostic error detection and avoidance: a College of American Pathologists Q-probes study of 1,667,547 accessioned cases in 359 laboratories. Arch. Pathol. Lab. Med. 1998, 122: 303-309.
18. Zarbo, R.J. Monitoring anatomic pathology practice through quality assurance measures. Clin. Lab. Med. 1999, 19: 713-742.
19. van de Wouw, A.J., Janssen-Heijnen, M.L., Coebergh, J.W., Hillen, H.F. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur. J. Cancer 2002, 38: 409-413.
20. Monzon, F.A., Dumur, C.I., Lyons-Weiler, M., Sciulli, C.M., Garrett, C.T., Hagenkord, J.M., Buturovic, L., Deeter, R., Becker, S.H., Rigl, C.T., Anderson, G.G. Clinical validation of a gene expression microarray-based tissue of origin test applied to primary and metastatic tumors. Annual Meeting of the Association for Molecular Pathology, November, 2006; Orlando, FL.
21. Dumur, C.I., Lyons-Weiler, M., Sciulli, C., Garrett, C.T., Schrijver, I., Holley, T.K., Rodriquez-Paris, J., Pollack, J.R., Zehnder, J.L., Price, M., Hagenkord, J.M., Rigl, C.T., Buturovic, L.J., Anderson, G.G., Monzon, F.A. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. J. Mol. Diagn. 2008, 10: 66-77.
22. Hainaut, P., Wiman, K.G. 25 Years of P53 Research. Springer, 2007, 11, p. 446.
23. Grollman, A.P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brdar, B., Slade, N., Turesky, R.J., Goodenough, A.K., Rieger, R., Vukelić, M., Jelaković, B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA 2007, 104: 12129-12134.
24. Lawrence, H.J., Truong, S., Patten, N., Nakao, A., Wu, L. detection of p53 mutations in cancer by the amplichip p53 test, a microarray-based resequencing assay. The third international workshop on mutation p53, November, 2007, Lyons, France.
25. Shaffer, L.G., Bui, T-H. Molecular cytogenetic and rapid aneuploidy detection methods in prenatal diagnosis. Am. J. Med. Genet. Part C Semin. Med. Genet. 2007, 145C: 87-98.
26. Bejjani, B.A., Shaffer, L.G. Application of array-based comparative genomic hybridization to clinical diagnostics. J. Mol. Diagn. 2006, 8: 528-553.
27. Kaiser, J. It's all about me. Science 2007, 318: 1843.
28. Pennisi, E. Human Genetic Variation. Science 2007, 318: 1842-1843.
29. Hayden, E.C. International genome project launched. Nature 2008, 451: 378-379.